Cell cycle progression following naive T cell activation is independent of Jak3/common γ-chain cytokine signals

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4493-4501

  Shi, Min ^a   Lin, Tsung H ^b   Appell, Kenneth C ^b   Berg, Leslie J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b PHARMACOPEIA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; JANUS KINASE 3; JANUS KINASE 3 INHIBITOR; INTERLEUKIN 2 RECEPTOR GAMMA; JAK3 PROTEIN, MOUSE; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CD4+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL PROLIFERATION; G0 PHASE; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; JANUS KINASE 3; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 70449728169     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804339     Document Type: Article

References (67)

1. 1 phase progression: cycling on cue. Cell 79: 551-555.
2. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, M. Nakamura, and T. Takeshita. 1995. The common γ-chain for multiple cytokine receptors. Adv. Immunol. 59: 225-277.
3. Smith, K. A. 1980. T-cell growth factor. Immunol. Rev. 51: 337-357.
4. Gillis, S., and K. A. Smith. 1977. In vitro generation of tumor-specific cytotoxic lymphocytes: secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. J. Exp. Med. 146: 468-482.
5. Morgan, D. A., F. W. Ruscetti, and R. Gallo. 1976. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193: 1007-1008.
6. Depper, J. M., W. J. Leonard, R. J. Robb, T. A. Waldmann, and W. C. Greene. 1983. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J. Immunol. 131: 690-696. (Pubitemid 13079034)
7. Malek, T. R., G. Ortega, J. P. Jakway, C. Chan, and E. M. Shevach. 1984. The murine IL 2 receptor: II. Monoclonal anti-IL-2 receptor antibodies as specific inhibitors of T cell function in vitro. J. Immunol. 133: 1976-1982. (Pubitemid 14035297)
8. Gillis, S., A. E. Gillis, and C. S. Henney. 1981. Monoclonal antibody directed against interleukin 2: I. Inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells. J. Exp. Med. 154: 983-988. (Pubitemid 11060805)
9. Modiano, J. F., J. Domenico, A. Szepesi, J. J. Lucas, and E. W. Gelfand. 1994. Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J. Biol. Chem. 269: 32972-32978.
10. Brennan, P., J. W. Babbage, B. M. Burgering, B. Groner, K. Reif, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7: 679-689.
11. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573.
12. cdc2 kinase activation in T lymphocytes. J. Biol. Chem. 268: 22737-22745.
13. 1 events and regulation of cell proliferation. Science 246: 603-608.
14. Khoruts, A., A. Mondino, K. A. Pape, S. L. Reiner, and M. K. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187: 225-236. (Pubitemid 28060438)
15. Leung, D. T., S. Morefield, and D. M. Willerford. 2000. Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo. J. Immunol. 164: 3527-3534.
16. Yu, A., J. Zhou, N. Marten, C. C. Bergmann, M. Mammolenti, R. B. Levy, and T. R. Malek. 2003. Efficient induction of primary and secondary T cell-dependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors. J. Immunol. 170: 236-242. (Pubitemid 36026145)
17. + T cell survival but not for antigen proliferation. Nat. Immunol. 1: 54-58.
18. Koretzky, G. A., R. P. Daniele, W. C. Greene, and P. C. Nowell. 1983. Evidence for an interleukin-independent pathway for human lymphocyte activation. Proc. Natl. Acad. Sci. USA 80: 3444-3447.
19. Cote-Sierra, J., G. Foucras, L. Guo, L. Chiodetti, H. A. Young, J. Hu-Li, J. Zhu, and W. E. Paul. 2004. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 101: 3880-3885.
20. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621-624.
21. + T lymphocytes form interleukin 2-deficient mice by costimulatory B7 molecules. Proc. Natl. Acad. Sci. USA 93: 2903-2908.
22. Van Parijs, L., A. Biuckians, A. Ibragimov, F. W. Alt, D. M. Willerford, and A. K. Abbas. 1997. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158: 3738-3745.
23. Malek, T. R., A. Yu, P. Scibelli, M. G. Lichtenheld, and E. K. Codias. 2001. Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J. Immunol. 166: 1675-1683.
24. Appleman, L. J., A. Berezovskaya, I. Grass, and V. A. Boussiotis. 2000. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164: 144-151.
25. kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 168: 2729-2736.
26. Boulougouris, G., J. D. McLeod, Y. I. Patel, C. N. Ellwood, L. S. Walker, and D. M. Sansom. 1999. IL-2-independent activation and proliferation in human T cells induced by CD28. J. Immunol. 163: 1809-1816.
27. kip1 expression in human peripheral T lymphocytes. Eur. J. Immunol. 29: 789-798.
28. Parry, R. V., K. Reif, G. Smith, D. M. Sansom, B. A. Hemmings, and S. G. Ward. 1997. Ligation of the T cell co-stimulatory receptor CD28 activates the serinethreonine protein kinase protein kinase B. Eur. J. Immunol. 27: 2495-2501.
29. Colombetti, S., F. Benigni, V. Basso, and A. Mondino. 2002. Clonal anergy is maintained independently of T cell proliferation. J. Immunol. 169: 6178-6186.
30. Colombetti, S., V. Basso, D. L. Mueller, and A. Mondino. 2006. Prolonged TCR/ CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J. Immunol. 176: 2730-2738.
31. Bennett, F., D. Luxenberg, V. Ling, I. M. Wang, K. Marquette, D. Lowe, N. Khan, G. Veldman, K. A. Jacobs, V. E. Valge-Archer, M. Collins, and B. M. Carreno. 2003. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 170: 711-718.
32. Stephenson, L. M., D. S. Park, A. L. Mora, S. Goenka, and M. Boothby. 2005. Sequence motifs in IL-4Rα mediating cell-cycle progression of primary lymphocytes. J. Immunol. 175: 5178-5185.
33. + T cell subsets. Int. Immunol. 19: 1191-1199.
34. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16: 293-322.
35. Malek, T. R., and A. L. Bayer. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. 4: 665-674.
36. Nelson, B. H., J. D. Lord, and P. D. Greenberg. 1996. A membrane-proximal region of the interleukin-2 receptor γ c chain sufficient for Jak kinase activation and induction of proliferation in T cells. Mol. Cell. Biol. 16: 309-317.
37. Oakes, S. A., F. Candotti, J. A. Johnston, Y. Q. Chen, J. J. Ryan, N. Taylor, X. Liu, L. Hennighausen, L. D. Notarangelo, W. E. Paul, et al. 1996. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5: 605-615.
38. c)-dependent signaling: comparative analysis of γc, Jak3, and γc and Jak3 double-deficient mice. Int. Immunol. 12: 123-132.
39. Yamaoka, K., P. Saharinen, M. Pesu, V. E. Holt III, O. Silvennoinen, and J. J. O'Shea. 2004. The Janus kinases (Jaks). Genome Biol. 5: 253.
40. Thomis, D. C., C. B. Gurniak, E. Tivol, A. H. Sharpe, and L. J. Berg. 1995. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270: 794-797.
41. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
42. Strasser, A., A. W. Harris, L. M. Corcoran, and S. Cory. 1994. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 368: 457-460. (Pubitemid 24115352)
43. Shi, M., T. H. Lin, K. C. Appell, and L. J. Berg. 2008. Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifnγ locus during T helper 1 cell differentiation. Immunity 28: 763-773. (Pubitemid 351778407)
44. Adachi, M., M. Sekiya, T. Torigoe, S. Takayama, J. C. Reed, T. Miyazaki, Y. Minami, T. Taniguchi, and K. Imai. 1996. Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor β c chain. Blood 88: 4118-4123. (Pubitemid 26399156)
45. von Freeden-Jeffry, U., N. Solvason, M. Howard, and R. Murray. 1997. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7: 147-154.
46. Vella, A. T., S. Dow, T. A. Potter, J. Kappler, and P. Marrack. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 3810-3815.
47. Vella, A., T. K. Teague, J. Ihle, J. Kappler, and P. Marrack. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186: 325-330.
48. 1 phase in primary human T lymphocytes. J. Biol. Chem. 268: 4113-4119.
49. + T cells. Eur. J. Immunol. 37: 2606-2616.
50. Hacker, G., A. Bauer, and A. Villunger. 2006. Apoptosis in activated T cells: what are the triggers, and what the signal transducers? Cell Cycle 5: 2421-2424.
51. Hildeman, D. A., Y. Zhu, T. C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16: 759-767.
52. You, H., M. Pellegrini, K. Tsuchihara, K. Yamamoto, G. Hacker, M. Erlacher, A. Villunger, and T. W. Mak. 2006. FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J. Exp. Med. 203: 1657-1663. (Pubitemid 44036270)
53. Mitchell, T. C., D. Hildeman, R. M. Kedl, T. K. Teague, B. C. Schaefer, J. White, Y. Zhu, J. Kappler, and P. Marrack. 2001. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat. Immunol. 2: 397-402.
54. Bauer, A., A. Villunger, V. Labi, S. F. Fischer, A. Strasser, H. Wagner, R. M. Schmid, and G. Hacker. 2006. The NF-κB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc. Natl. Acad. Sci. USA 103: 10979-10984.
55. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
56. Burchill, M. A., J. Yang, K. B. Vang, J. J. Moon, H. H. Chu, C. W. Lio, A. L. Vegoe, C. S. Hsieh, M. K. Jenkins, and M. A. Farrar. 2008. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28: 112-121.
57. Yao, Z., Y. Kanno, M. Kerenyi, G. Stephens, L. Durant, W. T. Watford, A. Laurence, G. W. Robinson, E. M. Shevach, R. Moriggl, et al. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109: 4368-4375.
58. + T-cell memory by cytokines and costimulators. Immunol. Rev. 211: 23-38.
59. + T cell memory by promoting the generation of IL-7Rα-expressing cells. J. Exp. Med. 204: 547-557.
60. + memory T cells. Nature 441: 890-893.
61. + T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J. Exp. Med. 204: 1803-1812.
62. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268: 1472-1476.
63. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521-530.
64. Larsen, C. P., S. C. Ritchie, R. Hendrix, P. S. Linsley, K. S. Hathcock, R. J. Hodes, R. P. Lowry, and T. C. Pearson. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152: 5208-5219.
65. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177: 925-935.
66. Lenschow, D. J., K. C. Herold, L. Rhee, B. Patel, A. Koons, H. Y. Qin, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5: 285-293.
67. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.